Peptide-Functionalized Iron Oxide Nanoparticles for Cancer Therapy: Targeting Strategies, Mechanisms, and...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Therapeutic peptides show promise in oncology but face challenges like poor stability and biodistribution.
• Iron oxide nanoparticles (IONPs) are biocompatible, magnetic nanomaterials suitable for drug delivery and imaging.

Purpose of the Study:

• To explore the potential of integrating peptides with IONPs for advanced cancer theranostics.
• To overcome the limitations of traditional peptide therapeutics in oncology.

Main Methods:

• Functionalizing IONPs with peptides for targeted delivery and enhanced tumor penetration.
• Utilizing IONPs for controlled drug release, MRI tracking, and magnetic hyperthermia.
• Investigating the impact of peptide-IONP hybrids on the tumor microenvironment (TME).

Main Results:

• Peptide-IONP conjugates demonstrate selective tumor targeting and improved tissue penetration.
• IONPs facilitate controlled delivery, enable MRI-based monitoring, and activate therapeutic mechanisms.
• These hybrids modulate the TME, enhancing drug accessibility and overcoming resistance.
• IONP's iron-driven chemistry can induce ferroptosis and autophagy, crucial for refractory tumors.

Conclusions:

• Peptide-IONP conjugates represent a novel class of hybrid systems for precision cancer nanomedicine.
• These theranostic agents combine targeting specificity, imaging, and therapeutic versatility.
• Advances in peptide engineering and nanotechnology accelerate the translational potential of these conjugates for next-generation cancer treatments.